Latest Annual Reports
by Mike Gee
08 July 2026









































Autodesk, Inc.
REVENUE
$7,206,000,000
17.53%
INCOME
$1,124,000,000
1.08%
EMPLOYEES
N/A
CUSTOMERS
N/A
Autodesk is a global leader in 3D design, engineering, and entertainment technology solutions serving architecture, engineering & construction, product design and manufacturing, and media & entertainment industries.
View Company PageFiled: 2026-03-03
Caris Life Sciences, Inc.
REVENUE
$812,033,000
96.97%
INCOME
-$68,088,000
75.85%
EMPLOYEES
1,846
CUSTOMERS
6,000
Patient-centric TechBio precision medicine company providing comprehensive molecular profiling, AI/ML-driven insights, and data licensing to support oncology care across early detection, MRD tracking, therapy selection, and treatment monitoring.
View Company PageFiled: 2026-03-03
Blue Owl Technology Income Corp.
REVENUE
$585,017,000
14.38%
INCOME
$284,097,000
11.58%
EMPLOYEES
130
CUSTOMERS
190
Blue Owl Technology Income Corp. is a Maryland-domiciled, externally managed closed-end business development company that originates and invests primarily in U.S. technology-related debt and equity—focused on software and related tech companies—to generate current income and capital appreciation.
View Company PageFiled: 2026-03-03
Blue Owl Credit Income Corp.
REVENUE
$3,149,487,000
22.79%
INCOME
$1,320,342,000
4.23%
EMPLOYEES
N/A
CUSTOMERS
370
Blue Owl Credit Income Corp. is an externally managed, closed-end Business Development Company that originates and holds predominantly floating-rate senior secured loans to U.S. middle-market companies to generate current income and opportunistic capital appreciation.
View Company PageFiled: 2026-03-03
Advantage Solutions Inc.
REVENUE
$3,542,642,000
-0.66%
INCOME
-$227,735,000
30.35%
EMPLOYEES
73,000
CUSTOMERS
4,000
Advantage Solutions Inc. provides outsourced sales, marketing, merchandising, sampling, and retailer support services to consumer packaged goods manufacturers and retailers across physical retail and digital commerce channels in North America.
View Company PageFiled: 2026-03-03
Arcturus Therapeutics Holdings Inc.
REVENUE
N/A
INCOME
-$65,783,000
18.73%
EMPLOYEES
111
CUSTOMERS
N/A
Arcturus Therapeutics is a San Diego-based biotech developing mRNA medicines and vaccines using its proprietary LUNAR delivery and STARR self-amplifying platforms, with near-term clinical programs in OTC deficiency and cystic fibrosis and a commercialized COVID-19 vaccine (KOSTAIVE) partnered with CSL Seqirus.
View Company PageFiled: 2026-03-03
Angel Oak Mortgage REIT, Inc.
REVENUE
N/A
INCOME
$44,024,000
53.13%
EMPLOYEES
N/A
CUSTOMERS
N/A
Angel Oak Mortgage REIT, Inc. is a U.S.-focused real estate finance REIT that acquires and invests primarily in newly originated non‑QM and other mortgage-related assets to generate risk‑adjusted returns via cash distributions and capital appreciation.
View Company PageFiled: 2026-03-03
Accel Entertainment, Inc.
REVENUE
$1,330,960,000
8.12%
INCOME
$51,272,000
45.28%
EMPLOYEES
1,600
CUSTOMERS
N/A
Accel Entertainment is a U.S. distributed gaming operator and developer/owner-operator of brick-and-mortar casinos and racinos that provides turnkey gaming terminals, redemption and amusement devices, and related services to bars, restaurants, retail locations, and horse racing venues.
View Company PageFiled: 2026-03-03
Amylyx Pharmaceuticals, Inc.
REVENUE
N/A
INCOME
-$144,735,000
52.03%
EMPLOYEES
136
CUSTOMERS
N/A
Clinical-stage pharmaceutical company developing therapies for rare endocrine/metabolic and neurodegenerative diseases, with lead programs avexitide (PBH, congenital HI) and AMX0035 (Wolfram syndrome).
View Company PageFiled: 2026-03-03
CalciMedica, Inc.
REVENUE
N/A
INCOME
-$29,600,000
-116.06%
EMPLOYEES
N/A
CUSTOMERS
N/A
Clinical-stage, pre-revenue biopharmaceutical company focused on CRAC channel inhibition with lead candidate Auxora and significant clinical, regulatory, and financing risks.
View Company PageFiled: 2026-03-03
ANAPTYSBIO, INC
REVENUE
$234,603,000
157.01%
INCOME
-$13,232,000
90.89%
EMPLOYEES
104
CUSTOMERS
2
AnaptysBio, Inc. is a clinical-stage immunology-focused biotechnology company developing antibody therapeutics (rosnilimab, ANB033, ANB101) and generating revenue from collaboration milestones and royalties (notably GSK's Jemperli and Vanda's imsidolimab).
View Company PageFiled: 2026-03-03
B&G Foods, Inc.
REVENUE
$1,828,687,000
-5.37%
INCOME
-$43,257,000
82.78%
EMPLOYEES
2,497
CUSTOMERS
10
B&G Foods, Inc. is a diversified packaged foods and household products company that manufactures, markets, and distributes a broad portfolio of branded shelf-stable and frozen foods across the United States, Canada, and Puerto Rico.
View Company Page